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Desmoplastic small round cell tumour (DSRCT) is an aggressive and a rare neoplasm. We report on a 34-year-old male who
had abdominal discomfort with a large intraperitoneal mass. Histological examination of the tumour biopsy revealed sheets of
small round cells. The cells were positive with vimentin and desmin (with occasional dot positivity) and negative for WT1 and
CD 99 with immunohistochemistry. Cytogenetics showed a translocation disrupting the EWSR 1 gene on 22 q 12 consistent
with DSRCT. Electron microscopic examination showed sparse cytoplasmic organelles. The patient succumbed 34 months from
disease presentation after multiple chemotherapies and thereafter radiotherapy. In summary, our case exempliﬁes that it is crucial
to combine clinical, histological, and molecular aspects in diagnosing DSRCT especially when characteristic dot positivity with
desmin is weak along with deﬁcient marking of WT1 and CD99 by immunohistochemistry. Histology was also less clear than
published examples of this entity with a poor desmoplastic response. A multidisciplinary approach including early referral to
specialised centres is recommended in these cases as tertiary referral centres will be required to substantiate the diagnosis.
1.Introduction
Desmoplastic small round cell tumour (DSRCT) is classiﬁed
as a soft tissue sarcoma. It is an aggressive and rare tumour
that primarily presents with an abdominal mass with only a
few cases having been reported in the literature [1]. Patients’
ages at diagnosis have ranged from 3 to 48 years with a mean
age of 21 years [2].
There are no risk factors that have been identiﬁed
speciﬁc to the disease. The tumour appears to arise from the
primitive cells of childhood and is considered a childhood
cancer. Research has indicated that there is a relationship
between desmoplastic small round cell tumour, Wilm’s
tumour, and Ewing’s sarcoma. Some DSRCT can present
clinically, simulating lymphoma or other solid tumours.
Therefore, careful selection of diagnostic tools should be
employed to diﬀerentiate between such tumours.
DSRCT is usually associated with a unique chromosomal
translocation t(11;22) (p13:q12) resulting in an EWS/WT1
transcript [3, 4] which is diagnostic of this tumour [5]. This
transcript codes for a protein that acts as a transcriptional
activator that fails to suppress tumour growth.
Due to the rarity of this tumour, many general practi-
tioners and oncologists are not familiar with the (DSRCT)
entity. DSRCT in young patients can be confused with other
abdominal tumours including lymphoma, rhabdomyosar-
coma, neuroblastoma, primitive neuroectodermal tumour,
small cell mesothelioma, Ewing’s sarcoma, and Wilm’s
tumour. Therefore, patients with the likelihood of DSRCT
should be referred to a sarcoma specialist centre where
adequate expertise would be available for the complex
diagnostic tests required for conﬁrmation of the entity.
There is no standard protocol for the treatment of the
disease. However, recent literature and studies have reported2 Case Reports in Oncological Medicine
that some patients respond to high-dose chemotherapy with
other modalities of treatment such as tumour debulking,
cytoreductive surgery, and radiation therapy [6]. Overall the
prognosis for DSRCT is poor with less than 20% surviving
beyond two to three years [7].
2. CaseStudy
We report on a 34-year-old male who presented in January
2008 to the Launceston General Hospital, Tasmania with 6-
month history of abdominal discomfort and pain on lying
on his stomach when surﬁng. There was no other signiﬁcant
past medical history other than tonsillectomy. He was a
social smoker and occasionally consumed alcohol. He had
a major weight loss from July 2007 until January 2008. He
did not have night sweats or any change in his appetite.
On examination, he was found to have a painful swelling
in the upper left quadrant of his abdomen. The hard mass
was about 15cm in diameter, extending down towards the
umbilicus.
His full blood count was normal. The liver and renal
function tests were normal. He was negative for hepatitis B
and C viruses as well as for HIV. His serum CA 125 level was
slightly high at 65U/mL (Normal <35) with other tumour
markers being within normal range except for serum lactate
dehydrogenase (LDH), which showed a mild increase. He
had evidence of past infection with Epstein Barr virus. The
cerebrospinal ﬂuid examination did not reveal any abnormal
lymphoid or malignant cells. On computer tomography
(CT) scan, he was found to have a large cystic intraperitoneal
mass with a suspicion of involvement of abdominal lymph
nodes. The soft tissue density was present in the area of
the pancreas, porta hepatis, para-aortic region and with
extension to the thorax where rounded densities over the
pericardial region were noted.
Two CT-guided biopsies were performed in January
and in early February 2008. The ﬁrst biopsy revealed
scanty material and showed only soft connective tissue.
The second biopsy had a small piece of ﬁbrous tissue
inﬁltrated by sheets of small cells resembling lymphoid cells.
Immunohistochemistry with lymphoma panel markers were
negative, and the tissue sample was not suﬃcient for further
studies. Subsequently, in February 2008, he underwent open
abdominal surgery, and a large mass in relation to the
pancreas was excised. The tumour was extending into the
lesser sac and into the right subphrenic space. Omentum was
also involved. Complete resection was not possible due to its
widespread tissue involvement. The resected specimen had
three lobulated greyish masses measuring 4 × 3 × 2cms.The
cut surface was soft, greyish, and uniform. Solid and semi-
cystic components were present. Frozen sections showed a
small blue round cell tumour. The ﬂow cytometry suggested
a nonhaematological malignancy.
Histologically, the tumour was composed of large sheets
of small round cells forming lobulated nodules (Figure 1).
The nuclei were small, hyperchromatic with indistinct
nucleoli and irregular nuclear membranes. There were also
some nuclear grooves and a few oval nuclei. There was only
Figure 1: Tumour tissue. There are sheets of small round cells
separated by ﬁbrous tissue (H&E).
Figure 2: Immunohistochemistry with desmin: perinuclear dot-
like staining (arrow).
minor variation in nuclear size. Mitotic ﬁgures were sparse.
No obvious necrosis was present. There were numerous
ectatictypevesselswithinthetumour.Attheperipheryofthe
tumour nodules there was a minimal desmoplastic stroma
betweensheetsoftumourcells.Themicroscopicappearances
suggested a small blue cell tumour with the diﬀerential
including DSRCT.
Immunohistochemical stains showed a patchy perinu-
clear staining pattern with desmin, but characteristic dot-
positivity was not prominent (Figure 2). There was focal
mild positive staining with neuron-speciﬁc enolase (NSE)
and moderate staining with AE1/AE3 along with some
patchy dot positivity with CAM 5.2. There was negative
staining with smooth muscle actin, calretinin, CD 45,
chromogranin A, TTF1, synaptophysin, and S100. EMA
showed only less than 5% of cells staining positive. The
tumour cells were negative with WT1 and CD 99. Although
there was initial clinical suspicion of lymphoma, CD 45
and other lymphoid markers were negative. Strong positivity
with vimentin and patchy perinuclear region staining with
desmin suggested that this lesion is likely to be a DSRCT.
Cytogenetic studies showed disruptions in the Ewing’s
sarcoma gene (∗22p 11 q), Wilm’s tumour gene by FISH
probe, and RT-PCR studies were repeated at the Sullivan
Nicolaides Pathology, Queensland and showed a positive
result with the Ewing’s sarcoma dual-colour break-apart
probe. This ﬁnding is consistent with DSRCT.Case Reports in Oncological Medicine 3
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Figure 3: Electron microscopy showing sparse cytoplasmic
organelles with short strips of rough endoplasmic reticulum and
mitochondria.
Electron microscopic examination showed a popula-
tion of primitive cells. The cytoplasmic organelles were
sparse with short strips of rough endoplasmic reticulum
and occasional mitochondria. The characteristic whorls of
intermediate ﬁlaments usually present in DSRCT were not
identiﬁed,andtherewerenodensecorecytoplasmicgranules
(Figure 3).Theultrastructuralfeaturesareconsistentwithan
undiﬀerentiated small cell tumour.
Due to the negative immunohistochemical markers for
WT1 and CD99 with positive ﬁndings for desmin and
vimentin it was still thought compatible with a DSRCT
even though histologically desmoplasia was minimal. The
histology and immunohistochemistry were forwarded for
reviewtotwospecialistcentresbecauseofambiguitywiththe
proposed diagnosis.
3. Discussion
The most acceptable consensus is that this case represents a
small round blue cell tumour without evidence of signiﬁcant
desmoplasiabutshouldnonethelessbeclassiﬁedasaDSRCT.
Moreover, the cells were negatively stained with both WT1
and CD 99, which is against DSRCT. However, Lae et al. [8]
reported that WT1-positive tumours were found in 91% and
CD99-positive tumours only in 23%. The unusual ﬁnding
here in our patient was that both WT 1 and CD 99 were
negative and that desmoplasia was minimal.
In a histopathological study [9]o f3 9c a s e so fD S R C T
most cases had shown the characteristic pattern of small blue
cells embedded in a dense ﬁbrous stroma. About one-third
of tumours exhibited a wide range of morphological features
such as a predominant component of spindle cells, presence
of Homer-Wright-like, rosettes and an insular pattern. The
recognition of these uncommon morphological variants of
DSRCTisofparamountimportancetoavoidmisdiagnosisas
these tumours can be confused with other neoplastic lesions.
I ns u m m a r y ,w ep r e s e n tad i ﬃcult case of a 34-year-old
man with an abdominal tumour simulating lymphoma. The
morphological pattern and immunohistochemistry favour
a diagnosis of DSRCT, but with less desmoplasia than is
usual. Cytogenetics performed on fresh tissue with FISH
showed a translocation disrupting the EWS gene on 22p
11q, with an EWS-WT1 gene fusion. The repeat FISH probe
and RT-PCR studies performed at the Sullivan Nicolaides
Pathology showed a positive result with Ewing’s sarcoma
dual-colour break-apart probe. This ﬁnding is consistent
with DSRCT. Electron microscopic studies were consistent
with an undiﬀe r e n t i a t e ds m a l lc e l lt u m o u ra sd e n s ec o r e
granules, characteristic of DSRCT, were not present. The
patient was referred to the Peter MacCallum Cancer Centre
in Melbourne for further management. He was treated
initially according to the VAC protocol [7], thereafter
with multiple chemotherapies and radiotherapy because of
widespread disease to the abdomen, liver, lung, and bones.
He died 28 months following the initial treatment (34
months after presentation).
For diagnosis of DSRCT a combination of clinical, his-
tological, and molecular aspects is required especially when
usual markers for the entity WT1 and CD99 are negative.
As desmoplasia is minimal and characteristic desmin dot
positive is scanty in our case we suggest all the above ﬁndings
indicate a variant of DSRCT. Finally a multidisciplinary
approach including early referral to a specialised centre is
recommended in such complex cases.
Acknowledgments
The authors would like to thank Louise Woods, Dr. David
Challis for photography and the Peter MacCallum Cancer
Centre for assessing the case and doing special tests.
References
[1] W. L. Gerald, H. K. Miller, H. Battifora, M. Miettinen, E. G.
Silva,andJ.Rosai,“Intra-abdominaldesmoplasticsmallround-
cell tumor: report of 19 cases of a distinctive type of high-
grade polyphenotypic malignancy aﬀecting young individuals,”
American Journal of Surgical Pathology, vol. 15, no. 6, pp. 499–
513, 1991.
[2] I. Leuschner, K. Radig, and D. Harms, “Desmoplastic small
round cell tumour,” Seminars in Diagnostic Pathology,p p .
13204–13212, 1996.
[3] A. J. Murphy, K. Bishop, C. Pereira et al., “A new molecular
variant of desmoplastic small round cell tumor: signiﬁcance of
WT1 immunostaining in this entity,” Human Pathology, vol. 39,
no. 12, pp. 1763–1770, 2008.
[4] W. L. Gerald and D. A. Haber, “The EWS-WT1 gene fusion
in desoplastic small round cell tumour,” Seminars in Cancer
Biology, vol. 15, pp. 197–205, 2005.
[5] Y.-S. Lee and C.-H. Hsiao, “Desmoplastic small round cell
tumor: a clinicopathologic, immunohistochemical and molec-
ular study of four patients,” Journal of the Formosan Medical
Association, vol. 106, no. 10, pp. 854–860, 2007.4 Case Reports in Oncological Medicine
[6] F. Talarico, D. Iusco, L. Negri, and D. Belinelli, “Combined
resection and multi-agent adjuvant chemotherapy for intra-
abdominal desmoplastic small round cell tumour: case report
and review of the literature,” Il Giornale di Chirurgia, vol. 28,
no. 10, pp. 367–370, 2007.
[7] F. Navid, V. M. Santana, C. A. Billups et al., “Concomi-
tant administration of vincristine, doxorubicine, cyclophos-
phamide, ifosfamide and etopside for high risk sarcomas,”
Cancer, vol. 106, pp. 1846–1856, 2006.
[8] M. E. Lae, P. C. Roche, L. Jin, R. V. Llyoid, and A. G.
Nascimento, “Desmoplastic small round cell tumour: clinico-
pathological, immunohistochemical and molecular study of 32
tumours,” American Journal of Surgical Pathology, vol. 26, pp.
823–835, 2002.
[9] N. G. Ord´ o˜ nez, “Desmoplastic small round cell tumor: I. A
histopathologic study of 39 cases with emphasis on unusual
histological patterns,” American Journal of Surgical Pathology,
vol. 22, no. 11, pp. 1303–1313, 1998.